MYCIO Wealth Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

MYCIO Wealth Partners’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-200	Closed	-$6K	–	220
2016 Q3	$6K	Hold	200	–	–	﹤0.01%	625
2016 Q2	$6K	Hold	200	–	–	﹤0.01%	620
2016 Q1	$6K	Hold	200	–	–	﹤0.01%	578
2015 Q4	$7K	Hold	200	–	–	﹤0.01%	567
2015 Q3	$7K	Hold	200	–	–	﹤0.01%	603
2015 Q2	$8K	Hold	200	–	–	﹤0.01%	541
2015 Q1	$7K	Hold	200	–	–	﹤0.01%	514
2014 Q4	$6K	Hold	200	–	–	﹤0.01%	501
2014 Q3	$5K	Hold	200	–	–	﹤0.01%	510
2014 Q2	$5K	Hold	200	–	–	﹤0.01%	527
2014 Q1	$5K	Hold	200	–	–	﹤0.01%	524
2013 Q4	$5K	Hold	200	–	–	﹤0.01%	501
2013 Q3	$5K	Buy	+200	New	+$4.18K	﹤0.01%	453

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

MYCIO Wealth Partners's ACAD Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of Acadia Pharmaceuticals (ACAD) in Q4 2016, closing a stake of 200 shares — an estimated $6K sold.

MYCIO Wealth Partners first reported a position in ACAD in Q3 2013 and held it in 13 quarters. The position peaked at $8K in Q2 2015. 225 funds tracked by Wall St. Rank hold ACAD as of Q4 2016.

MYCIO Wealth Partners reported no remaining Acadia Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
MYCIO Wealth Partners sold 200 Acadia Pharmaceuticals shares in Q4 2016, an estimated $6K.
MYCIO Wealth Partners first reported a position in Acadia Pharmaceuticals in Q3 2013 and held it in 13 quarters.
MYCIO Wealth Partners's Acadia Pharmaceuticals position peaked at $8K in Q2 2015.
225 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.